AzTrials
AzTrials

Smoking CessationNCT04657250

mHealth for Smoking Cessation in Public Housing

A study testing Smoking cessation + quitline linkage text messages and Passive quitline referral in people with Smoking Cessation, run by George Washington University at 1 site in United States.

Withdrawn

Withdrawn. The study stopped before anyone enrolled.

Official record
Search all trials

Trial summary

Smoking rates among public housing residents are more than twice as high as in the general population. In August 2018, the U.S. Department of Housing and Urban Development (HUD) required all public housing in the U.S. to become smoke-free. Read more about this study

Who is it for?
Ages 18 years and olderHealthy volunteers can take part
Conditions the study is for
Smoking Cessation
What is being tested?
Smoking cessation + quitline linkage text messages and Passive quitline referral
Could I receive a placebo?
Yes, some participants may receive a placebo
How many people
0 participants
Where
1 siteUnited States
Study dates
26 Oct 2020to 31 Jul 2022
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • All sexes
  • Healthy volunteers accepted
  • Adult, Older adult

Who may be able to join

  • 18 years or older
  • resident of D.C. public housing
  • smoked a cigarette in the 7 days prior to screening (self-report)
  • has daily access to a working cell phone with an unlimited text message plan

Who cannot join

  • -

Trial locations and contacts

1 site in 1 country.

United States1 site
  • George Washington University

    Washington D.C., District of Columbia, 20052

Other trials in United States

About this study

Smoking rates among public housing residents are more than twice as high as in the general population. In August 2018, the U.S. Department of Housing and Urban Development (HUD) required all public housing in the U.S. to become smoke-free. While HUD recommended that Public Housing Authorities provide smoking cessations services, at present, the D.C. Housing Authority (DCHA) does not offer any cessation services to its residents. Low-income smokers face unique challenges to smoking cessation and require sustained support for smoking cessation. Digital interventions such as text messaging programs and quitline (QL) phone counseling are scalable, evidence-based interventions for smoking cessation that can provide support over an extended timeframe at low cost.

The aim of this proposed research is to conduct a feasibility trial to assess the acceptability, levels of engagement, and preliminary efficacy of an integrated program that combines text-messaging for smoking cessation and text messages providing proactive linkage to the quitline compared to a single passive quitline text message referral among DCHA residents. The investigators hypothesize that the integrated program (combining text messages for smoking cessation and proactive quitline linkage) will yield significantly higher rates of quit attempts than passive quitline referral only.

Being tested
Smoking cessation + quitline linkage text messages, Passive quitline referral
Keywords
mobile phone, mHealth, text messaging
Medical subject headings
Smoking Cessation

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Smoking cessation + quitline linkage text messagesBehavioural

    Smoking cessation text messages will provide behavioral skills and support for quitting smoking. Quitline linkage text messages will include contact information for the quitline, option to be contacted by the quitline and active referral to the quitline upon setting a Quit Date.

  • Passive quitline referralBehavioural

    Single text message with contact information for the Quitline

Study groups in NCT04657250
Study groupRoleWhat they receive
Smoking cessation + quitline linkage text messagesExperimentalText messaging for smoking cessation + text messages with proactive linkage to quitline
Receives: Behavioral: Smoking cessation + quitline linkage text messages
Passive quitline referralPlacebo comparatorSingle text message with contact information for the Quitline
Receives: Behavioral: Passive quitline referral

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Proportion of participants making a quit attempt

    not smoking for 24 hours or more because trying to quit smoking

    Measured: 3 months

Secondary outcomes (2)
  1. Proportion of participants who quit smoking

    self reported 7 day point prevalence abstinence

    Measured: 3 months

  2. Number of cigarettes smoked per day

    change in number of cigarettes smoked per day between baseline and follow-up

    Measured: 3 months

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted8 Dec 2020
  2. Study start26 Oct 2020
  3. Primary completion30 Jun 2022 (estimated)
  4. Study completion31 Jul 2022 (estimated)

Why it stopped: COVID-19

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Health services research
Allocation
Randomised
Intervention model
Parallel groups
Masking
None (open label)
Enrolment
0 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT04657250
Sponsor's protocol ID
NCR191457
Status last verified
Nov 2022
First submitted
1 Dec 2020
Last updated
8 Nov 2022
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No

Questions about this trial

What is this clinical trial studying?

A study testing Smoking cessation + quitline linkage text messages and Passive quitline referral in people with Smoking Cessation, run by George Washington University at 1 site in United States.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 4 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: withdrawn, as of the sponsor's last update on 8 Nov 2022. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in United States. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. Some participants in this study may receive a placebo. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study was withdrawn before enrolling participants, so there are no results.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Proportion of participants making a quit attempt (time frame: 3 months). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 8 Nov 2022.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in